Health

The World Health Organisation (WHO) has announced that COVID-19 is no longer a public health emergency of international concern (Pheic). This declaration marks the end of the emergency response period that began in January 2020. The WHO has also unveiled a new strategy to transition from an emergency response to longer-term sustained COVID-19 disease management.
0 Comments
Nightmares are a common problem that affects many people. Not only do they disturb sleep, but they are also linked to other health issues such as anxiety and poor-quality sleep. Researchers have been investigating ways to help reduce the frequency and severity of nightmares, and a recent study suggests that non-invasive techniques can help manipulate
0 Comments
Glioblastoma is a malignant brain tumor known for its aggressiveness and difficulty to treat. However, a new hydrogel treatment has shown promising results in eliminating glioblastoma tumors in mice. The Hydrogel Treatment The hydrogel treatment uses paclitaxel, a chemotherapy drug, to create nano-sized filaments for insertion into the brain. The hydrogel covers the cancer cavity
0 Comments
Researchers at North Carolina State University (NCSU) have discovered that senior dogs with cognitive decline experience disruptions similar to those found in people with Alzheimer’s disease. This study suggests that dogs could provide a good model for research on Alzheimer’s. The Study The researchers recorded the brain waves of 28 senior dogs, some with cognitive
0 Comments
A team of surgeons from two US hospitals have successfully repaired a major malformation in a fetal brain. The surgery, which was guided by ultrasound and involved embolization, treated a rare prenatal condition known as vein of Galen malformation. This condition allows blood to flow dangerously fast through the brain after birth. The successful procedure
0 Comments
Alzheimer’s treatments have experienced a revival, with pharma giant Eli Lilly announcing that its experimental drug donanemab has successfully slowed cognitive and functional decline in patients with early-stage Alzheimer’s. Although neither donanemab nor a similar drug called Leqembi amount to a cure for Alzheimer’s, which affects around 6.5 million Americans, Wall Street analysts estimate that
0 Comments